Towards improved health service quality in Tanzania: contribution of a supportive supervision approach to increased quality of primary healthcare.


Journal

BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677

Informations de publication

Date de publication:
20 Nov 2019
Historique:
received: 07 01 2019
accepted: 16 10 2019
entrez: 22 11 2019
pubmed: 22 11 2019
medline: 18 2 2020
Statut: epublish

Résumé

Universal Health Coverage only leads to the desired health outcomes if quality of health services is ensured. In Tanzania, quality has been a major concern for many years, including the problem of ineffective and inadequate routine supportive supervision of healthcare providers by council health management teams. To address this, we developed and assessed an approach to improve quality of primary healthcare through enhanced routine supportive supervision. Mixed methods were used, combining trends of quantitative quality of care measurements with qualitative data mainly collected through in-depth interviews. The former allowed for identification of drivers of quality improvements and the latter investigated the perceived contribution of the new supportive supervision approach to these improvements. The results showed that the new approach managed to address quality issues that could be solved either solely by the healthcare provider, or in collaboration with the council. The new approach was able to improve and maintain crucial primary healthcare quality standards across different health facility level and owner categories in various contexts. Together with other findings reported in companion papers, we could show that the new supportive supervision approach not only served to assess quality of primary healthcare, but also to improve and maintain crucial primary healthcare quality standards. The new approach therefore presents a powerful tool to support, guide and drive quality improvement measures within council. It can thus be considered a suitable option to make routine supportive supervision more effective and adequate.

Sections du résumé

BACKGROUND BACKGROUND
Universal Health Coverage only leads to the desired health outcomes if quality of health services is ensured. In Tanzania, quality has been a major concern for many years, including the problem of ineffective and inadequate routine supportive supervision of healthcare providers by council health management teams. To address this, we developed and assessed an approach to improve quality of primary healthcare through enhanced routine supportive supervision.
METHODS METHODS
Mixed methods were used, combining trends of quantitative quality of care measurements with qualitative data mainly collected through in-depth interviews. The former allowed for identification of drivers of quality improvements and the latter investigated the perceived contribution of the new supportive supervision approach to these improvements.
RESULTS RESULTS
The results showed that the new approach managed to address quality issues that could be solved either solely by the healthcare provider, or in collaboration with the council. The new approach was able to improve and maintain crucial primary healthcare quality standards across different health facility level and owner categories in various contexts.
CONCLUSION CONCLUSIONS
Together with other findings reported in companion papers, we could show that the new supportive supervision approach not only served to assess quality of primary healthcare, but also to improve and maintain crucial primary healthcare quality standards. The new approach therefore presents a powerful tool to support, guide and drive quality improvement measures within council. It can thus be considered a suitable option to make routine supportive supervision more effective and adequate.

Identifiants

pubmed: 31747932
doi: 10.1186/s12913-019-4648-2
pii: 10.1186/s12913-019-4648-2
pmc: PMC6865029
doi:

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

848

Subventions

Organisme : Novartis Foundation
ID : NA

Références

Bull World Health Organ. 2016 Mar 1;94(3):160-160A
pubmed: 27403474
Trop Med Health. 2016 Jul 19;44:21
pubmed: 27462185
J Health Econ. 2015 Sep;43:154-69
pubmed: 26302940
Trop Med Int Health. 2017 Jan;22(1):92-102
pubmed: 27928874
Rural Remote Health. 2012;12:2072
pubmed: 22934936
Malar J. 2012 Feb 18;11:48
pubmed: 22340941
Hum Resour Health. 2017 Sep 2;15(1):58
pubmed: 28865466
J Healthc Qual. 2000 Sep-Oct;22(5):34-9
pubmed: 11184028
AIDS. 2015 Jul;29 Suppl 2:S175-7
pubmed: 26102628
Hum Resour Health. 2006 Mar 07;4:6
pubmed: 16522213
BMC Health Serv Res. 2019 Jan 22;19(1):55
pubmed: 30670011
Global Health. 2016 Nov 25;12(1):77
pubmed: 27884185
Soc Sci Med. 2006 Nov;63(9):2330-40
pubmed: 16887245
Int J Health Plann Manage. 2012 Oct-Dec;27(4):327-47
pubmed: 22714251
Health Econ. 2010 Dec;19(12):1461-77
pubmed: 19960481
BMC Med Res Methodol. 2013 Sep 18;13:117
pubmed: 24047204
Int J Qual Health Care. 2005 Oct;17(5):391-9
pubmed: 15951311
BMC Health Serv Res. 2014 Sep 16;14:392
pubmed: 25227620
Int J Gynaecol Obstet. 2015 Jun;130 Suppl 2:S17-24
pubmed: 26115852
PLoS One. 2015 Aug 28;10(8):e0135013
pubmed: 26317510
Ann Afr Med. 2013 Oct-Dec;12(4):243-51
pubmed: 24309414
J Clin Epidemiol. 2014 Mar;67(3):267-77
pubmed: 24275499
PLoS Med. 2014 Sep 22;11(9):e1001731
pubmed: 25243899
Health Policy Plan. 2015 Jun;30(5):675-86
pubmed: 24895350
Bull World Health Organ. 2017 Jun 1;95(6):397-407
pubmed: 28603306
Curr Drug Saf. 2007 Jan;2(1):19-23
pubmed: 18690946
PLoS One. 2013;8(3):e58415
pubmed: 23555581
Lancet. 2012 Sep 8;380(9845):859
pubmed: 22959368
Hum Resour Health. 2007 Nov 29;5:26
pubmed: 18047678
Int J Gynaecol Obstet. 2016 Jan;132(1):117-25
pubmed: 26653397
BMC Health Serv Res. 2016 Oct 13;16(1):578
pubmed: 27737679
Int J Qual Health Care. 2014 Apr;26(2):117-23
pubmed: 24481053
Bull World Health Organ. 2017 Jun 1;95(6):389-389A
pubmed: 28603302
PLoS One. 2018 Sep 7;13(9):e0202735
pubmed: 30192783
Trop Med Int Health. 2011 Oct;16(10):1225-33
pubmed: 21729221
Ann Emerg Med. 1995 Nov;26(5):590-4
pubmed: 7486367
J Dev Econ. 2016 Jan 1;118:112-132
pubmed: 26681821
Lancet. 2018 Jun 2;391(10136):2236-2271
pubmed: 29893224
BMJ Open. 2016 Sep 22;6(9):e010317
pubmed: 27660313
BMC Health Serv Res. 2014 Jun 20;14:275
pubmed: 24950878
Int J Qual Health Care. 2012 Dec;24(6):553-7
pubmed: 23074183
Hum Resour Health. 2012 Feb 22;10:3
pubmed: 22357353
Jt Comm J Qual Patient Saf. 2016 Aug;42(8):350-71
pubmed: 27456416
Implement Sci. 2014 Apr 02;9(1):41
pubmed: 24690284
Int J Health Plann Manage. 2014 Oct-Dec;29(4):e368-82
pubmed: 25551166
Lancet. 2013 May 18;381(9879):1747-55
pubmed: 23683641
BMC Health Serv Res. 2014 Jan 18;14:23
pubmed: 24438556
Lancet. 2005 Sep 17-23;366(9490):1026-35
pubmed: 16168785
BMC Public Health. 2014 Mar 25;14:277
pubmed: 24666561
Int J Qual Health Care. 2016 Oct;28(5):586-593
pubmed: 27488477
Soc Sci Med. 2017 May;181:54-65
pubmed: 28371629
Health Policy Plan. 2014 Sep;29(6):753-62
pubmed: 24038076
Int J Qual Health Care. 2017 Feb 1;29(1):32-39
pubmed: 27920249
Int J Health Care Qual Assur. 2018 Apr 16;31(3):190-202
pubmed: 29687759

Auteurs

Sabine Renggli (S)

Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, P.O. Box, 4002, Basel, Switzerland. sabine.renggli@bluewin.ch.
University of Basel, Basel, Switzerland. sabine.renggli@bluewin.ch.

Iddy Mayumana (I)

Ifakara Health Institute, Dar es Salaam/Ifakara, United Republic of Tanzania.

Dominick Mboya (D)

Ifakara Health Institute, Dar es Salaam/Ifakara, United Republic of Tanzania.

Christopher Charles (C)

Ifakara Health Institute, Dar es Salaam/Ifakara, United Republic of Tanzania.

Christopher Mshana (C)

Ifakara Health Institute, Dar es Salaam/Ifakara, United Republic of Tanzania.

Flora Kessy (F)

Ifakara Health Institute, Dar es Salaam/Ifakara, United Republic of Tanzania.

Tracy R Glass (TR)

Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, P.O. Box, 4002, Basel, Switzerland.
University of Basel, Basel, Switzerland.

Christian Lengeler (C)

Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, P.O. Box, 4002, Basel, Switzerland.
University of Basel, Basel, Switzerland.

Alexander Schulze (A)

Swiss Agency for Development and Cooperation, Berne, Switzerland.

Ann Aerts (A)

Novartis Foundation, Basel, Switzerland.

Constanze Pfeiffer (C)

Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, P.O. Box, 4002, Basel, Switzerland.
University of Basel, Basel, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH